As Greater Boston’s biotech industry sheds jobs, three unlikely regions are showing promise as up-and-coming hubs.

Osanni launched three years ago with a $27 million series A and has kept purposefully quiet ever since, founder and CEO ...

Biotech investors, executives and analysts worry that blanket bans on deals with Chinese companies could curb domestic ...

It has been a banner year for biotech buyouts, and these are two of the prime targets.

It might pull it off, provided several things fall right in place.

Visitors have said that the pool looks "absolutely beautiful" in the last day.

Merck broadens life sciences reach. Acquisition strengthens research capabilities. Biotech expansion supports long-term ...

Epicrispr's epigenetic editor EPI-321 lead to an average increase in lean muscle of about 0.8 pounds six months after treatment. (iStock / Getty Images Plus) Epicrispr Biotechnologies has used its ...

A flock of Korean biopharmaceutical and biotechnology companies are heading to San Diego this week with their eyes on expanding global partnerships and securing ...

Nebraska shows how America’s Heartland can power U.S. bioeconomy leadership by linking innovation in agriculture, research, ...

AI is at the heart of the recently announced deal. The post Up more than 550% in a year, why is this ASX biotech charging ...

A new era has arrived for Madison Square Garden Sports Corp. — and it begins with the Rangers. MSG executive chairman and CEO ...